Report cover image

Spinal Cord Injury Therapeutics Market, By Drug Type (Corticosteroids, Muscle Relaxants and Anti-spastic Drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Anti-depressants, Anticonvulsants, Others), By Indication (Complete Spinal Cord Injury, Incompl

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 190 Pages
SKU # CMI20007957

Description

The global spinal cord injury therapeutics market comprises therapeutics used for the treatment of spinal cord injury such as corticosteroids, non-steroidal anti-inflammatory drugs (NSAID’S), muscle relaxants, and anti-depressants. There are two types of spinal cord injuries including complete spinal cord injury and incomplete spinal cord injury and various causes of spinal cord injuries include brain injury, trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections.

Market Dynamics

Key players are focusing on product approvals to strengthen their position in the global spinal cord injury therapeutics market. For instance, in September 2020, AbbVie Inc., received an orphan drug and fast track designation from the U.S. Food and Drug Administration for Elezanumab, an investigational monoclonal antibody RGMa inhibitor for the treatment of spinal cord injury.

Key features of the study:
  • This report provides in-depth analysis of the global spinal cord injury therapeutics market, provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global spinal cord injury therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Zydus Cadila, ReNetX Bio, Inc., InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc., Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc., RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc., ScieGen Pharmaceuticals, Inc., MSN Laboratories Private Limited, and Lannett Co Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market
Detailed Segmentation:
  • Global Spinal Cord Injury Therapeutics Market, By Injury Type:
  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury
  • Global Spinal Cord Injury Therapeutics Market, By Drug Type:
  • Corticosteroids
  • Muscle Relaxants and Anti-spastic drugs
  • Non-steroidal Anti-inflammatory drugs (NSAIDs)
  • Anti-depressants
  • Anticonvulsants
  • Others
  • Global Spinal Cord Injury Therapeutics Market, By Application:
  • Autonomic Dysreflexia (AD)
  • Spasticity & Inflammation
  • Pain Management
  • Depression
  • Global Spinal Cord Injury Therapeutics Market, By Route of Administration:
  • Oral
  • Intravenous
  • Global Spinal Cord Injury Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Spinal Cord Injury Therapeutics Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Pfizer Inc.
  • Reddy's Laboratories Ltd.
  • Zydus Cadila
  • ReNetX Bio, Inc.
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc.
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc.
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc.
  • ScieGen Pharmaceuticals, Inc.
  • MSN Laboratories Private Limited
  • Lannett Co Inc.

Table of Contents

190 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Indication
Market Snippet, By Application
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Muscle Relaxants and Anti-spastic Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Non-steroidal Anti-inflammatory Drugs (NSAID’S)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Anti-depressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Anticonvulsants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Complete Spinal Cord Injury
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Incomplete Spinal Cord Injury
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
7. Global Spinal Cord Injury Therapeutics Market, By Application, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Autonomic Dysreflexia (AD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Spasticity and Inflammation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Depression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
10. Global Spinal Cord Injury Therapeutics Market, By Region, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2020 - 2032, (US$ Bn
Market Size and Forecast, Y-o-Y Growth and By Application, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
U.S.
Canada
Europe
Asia Pacific
Latin America
Middle East
Africa
11. Competitive Landscape
Company Profiles
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
AbbVie Inc
Pfizer Inc.
Reddy's Laboratories Ltd
Zydus Cadila
ReNetX Bio, Inc
InVivo Therapeutics Holdings
Lineage Cell Therapeutics, Inc
Kringle Pharma, Inc.
Acorda Therapeutics, Inc.
Bioaxone Biosciences, Inc
RespireRx Pharmaceuticals Inc.
NervGen
Rising Pharmaceuticals, Inc
ScieGen Pharmaceuticals, Inc
MSN Laboratories Private Limited
Lannett Co Inc.
Other Prominent Players
12. Section
References
Research Methodology
About us and Sales Contact
*Browse 54 market data tables and 43 figures on “Global Spinal Cord Injury Therapeutics Market” - Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us